Trial intelligence / Profile preview

Comparison of Peptide and Whole Protein Enteral Nutrition in ICU Patients With High-risk PEI

NCT07709611Phase 4Not yet recruiting

Sponsor
Shanghai Tenth People's Hospital
Start
Jul 2026
Primary completion
Nov 2027
Countries
1
01

Overview

Phase 4, randomised trial in pancreatic exocrine insufficiency (EPI) (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Branched-chain amino acid concentration at 1 week, Citrulline concentration at 1 week and 1 more. Planned start Jul 2026; status: not yet recruiting.

02

Conditions

pancreatic exocrine insufficiency (EPI)

Beyond the preview

Go deeper on NCT07709611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07709611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call